First Horizon Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 104 shares of BMRN stock, worth $6,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104

Previous 576 81.94%

Holding current value

$6,816

Previous $47,000 85.11%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$69.02 - $93.84 $32,577 - $44,292	-472 Reduced 81.94%	104 $7,000
Q4 2023 Feb 06, 2024	BUY	$76.22 - $98.51 $10,975 - $14,185	144 Added 33.33%	576 $55,000
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $6,847 - $7,923	-79 Reduced 15.46%	432 $37,000
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $1,213 - $1,629	15 Added 3.02%	511 $52,000
Q3 2022 Nov 09, 2022	SELL	$82.16 - $96.94 $3,204 - $3,780	-39 Reduced 7.29%	496 $41,000
Q2 2022 Aug 02, 2022	BUY	$71.48 - $86.85 $34,810 - $42,295	487 Added 1014.58%	535 $44,000
Q1 2022 May 10, 2022	SELL	$74.28 - $92.69 $15,301 - $19,094	-206 Reduced 81.1%	48 $4,000
Q4 2021 Feb 09, 2022	BUY	$71.72 - $91.47 $143 - $182	2 Added 0.79%	254 $22,000
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $12,860 - $14,700	172 Added 215.0%	252 $19,000
Q3 2021 Nov 09, 2021	SELL	$74.77 - $85.47 $43,441 - $49,658	-581 Reduced 87.9%	80 $6,000
Q2 2021 Aug 09, 2021	SELL	$75.51 - $84.79 $4,228 - $4,748	-56 Reduced 7.81%	661 $55,000
Q1 2021 May 11, 2021	BUY	$74.73 - $90.69 $4,558 - $5,532	61 Added 9.3%	717 $54,000
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $14,812 - $18,400	204 Added 45.13%	656 $57,000
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $4,312 - $7,861	60 Added 15.31%	452 $34,000
Q1 2020 May 05, 2020	BUY	$71.37 - $96.85 $4,210 - $5,714	59 Added 17.72%	392 $33,000
Q3 2019 Oct 23, 2019	BUY	$67.4 - $85.11 $20,354 - $25,703	302 Added 974.19%	333 $22,000
Q1 2019 Apr 26, 2019	BUY	$84.2 - $98.62 $2,610 - $3,057	31 New	31 $0
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $560 - $742	-7 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$76.01 - $99.03 $532 - $693	7 New	7 $0

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History